CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300409740
- Phone
- (415) 651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-11 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Sale | −17,950 | $8.66 | $155K | 543,955 |
| 2024-12-11 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Sale | −406 | $9.39 | $4K | 543,549 |
| 2024-12-11 | Bohen Sean PRESIDENT AND CEO | Sale | −55,907 | $8.66 | $484K | 242,929 |
| 2024-12-11 | Bohen Sean PRESIDENT AND CEO | Sale | −1,267 | $9.39 | $12K | 241,662 |
| 2024-12-10 | Harmon Cyrus Director | Sale | −8,256 | $9.37 | $77K | 772,277 |
| 2024-12-10 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | −12,452 | $9.38 | $117K | 611,947 |
| 2024-12-10 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Sale | −13,283 | $9.37 | $124K | 130,031 |
| 2024-12-10 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Sale | −16,803 | $9.37 | $157K | 561,905 |
| 2024-12-10 | Bohen Sean PRESIDENT AND CEO | Sale | −52,328 | $9.37 | $490K | 298,836 |
| 2024-12-09 | Harmon Cyrus Director | Grant or award | +29,250 | 780,533 | ||
| 2024-12-09 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Grant or award | +48,750 | 624,399 | ||
| 2024-12-09 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Grant or award | +52,000 | 143,314 | ||
| 2024-12-09 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Grant or award | +68,250 | 578,708 | ||
| 2024-12-09 | Bohen Sean PRESIDENT AND CEO | Grant or award | +204,750 | 351,164 | ||
| 2024-12-04 | BVF PARTNERS L P/IL Director | Returned to the company | −1,797,527 | 2,891,427 | ||
| 2024-12-04 | BVF PARTNERS L P/IL Director | Returned to the company | −1,418,736 | 2,165,776 | ||
| 2024-12-04 | BVF PARTNERS L P/IL Director | Returned to the company | −153,441 | 370,710 | ||
| 2024-12-04 | BVF PARTNERS L P/IL Director | Grant or award · Pre-Funded Warrant | +1,797,527 | 1,797,527 | ||
| 2024-12-04 | BVF PARTNERS L P/IL Director | Grant or award · Pre-Funded Warrant | +1,418,736 | 1,418,736 | ||
| 2024-12-04 | BVF PARTNERS L P/IL Director | Grant or award · Pre-Funded Warrant | +153,441 | 153,441 |
Page 7 of 11 · 207 trades